trial

Pharmacologic Treatment in Legal Offenders With Schizophrenia, a Prospective Observational Mirror Image Study.

NCTId NCT05939765
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Withdrawn
Enrollment 0 (actual)
Sponsored by Psychiatric University Hospital, Zurich
Primary completion 2025-12-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Withdrawn
Enrollment
0 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2025-12-01
Primary completion
2025-12-01
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Antipsychotic

Sponsors

Psychiatric University Hospital, ZurichLead Sponsor

Investigators

1
Stephan T. Egger, MD, PhDPrincipal Investigator

Sites

1 total
Zurich, Switzerland

Facts & assertions

4 sourced
Enrollment
0
Phase
NA
Primary Completion Date
2025-12-01
Status
WITHDRAWN
relationships
The graph out of here
drug
Antipsychotic
drug
lead_sponsor
Psychiatric University Hospital, Zurich
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Stephan T. Egger, MD, PhD
person